Ophthalmologic features of the common spinocerebellar ataxias

Current Opinion in Ophthalmology

Volumn 21, Issue 6, 2010, Pages 447-453

  Pula, John H ^a   Gomez, Christopher M ^b   Kattah, Jorge C ^a  

^a UNIVERSITY OF ILLINOIS   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

autosomal dominant cerebellar ataxia; olivopontocerebellar atrophy; progressive ataxia syndromes; SCA; spinocerebellar ataxia

Indexed keywords

GLUTAMINE; POLYGLUTAMINE;

AUTOSOMAL DOMINANT DISORDER; CLINICAL FEATURE; DIAGNOSTIC IMAGING; EYE DISEASE; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; HUMAN; OLIVOPONTOCEREBELLAR ATROPHY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SPINOCEREBELLAR DEGENERATION;

HUMANS; OCULOMOTOR NERVE DISEASES; SPINOCEREBELLAR ATAXIAS;

EID: 78049246333     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/ICU.0b013e32833eaf71     Document Type: Review

References (37)

1. Kattah JC, Kolsky MP, Guy J, O'Doherty D. Primary position vertical nystagmus and cerebellar ataxia. Arch Neurol 1983; 40:310-314.
2. Cha YH, Lee H, Jen JC, et al. Episodic vertical oscillopsia with progressive gait ataxia: clinical description of a new episodic syndrome and evidence of linkage to chromosome 13q. J Neurol Neurosurg Psychiatry 2007; 78:1273-1275.
3. Lynch DR, Farmer J. Practical approaches to neurogenetic disease. J Neuroophthalmol 2002; 22:297-304.
4. Mascalchi M. Spinocerebellar ataxias. Neurol Sci 2008; 29:S311 -S313.
5. Schmitz-Hubsch T, Coudert M, Bauer P. Spinocerebellar ataxia types 1,2,3, and 6. Neurology 2008; 71:982-989.
6. Buttner N, Geschwind D, Jen J, et al. Oculomotor phenotypes in autosomal dominant ataxias. Arch Neurol 1998; 55:1353-1357.
7. Rivaud-Pechoux S, Durr A, Gaymard B, et al. Eye movement abnormalities correlate with genotype in autosomal dominant cerebellar ataxia type I. Ann Neurol 1998; 43:297-302.
8. Schols L, Amoiridis G, Buttner T, et al. Autosomal dominant cerebellar ataxia: phenotypic differences in genetically defined subtypes? Ann Neurol 1997; 42:924-932.
9. Robitaille Y, Schut L, Kish S. Structural and immunocytochemical features of olivopontocerebellar atrophy caused by the spinocerebellar ataxia type 1 (SCA-1) mutation define a unique phenotype. Acta Neuropath 1995; 90:572-581.
10. Lee WY, Jin DK, Oh MR, et al. Frequency analysis and clinical characterization of spinocerebellar ataxia types 1, 2, 3, 6, and 7 in Korean patients. Arch Neurol 2003; 60:858-863;
11. Erratum: Arch Neurol 2003; 60:1256.
12. Abele M, Burk K, Andres F, et al. Autosomal dominant cerebellar ataxia type I. Nerve conduction and evoked potential studies in families with SCA1, SCA2 and SCA3. Brain 1997; 120:2141-2148.
13. Orr HT, Chung M, Banfi S, et al. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nature Genet 1993; 4:221-226.
14. Zoghbi H, Orr H. Pathogenic mechanisms of a polyglutamine-mediated neurodegenerative disease, spinocerebellar ataxia type 1. J Biol Chem 2009; 284:7425-7429.
15. Kang S, Hong S. Molecular pathogenesis of spinocerebellar ataxia type 1 disease. Mol Cells 2009; 27:621-627.
16. Burk K, Abele M, Fetter M, et al. Autosomal dominant cerebellar ataxia type I: clinical features and MRI in families with SCA1, SCA2 and SCA3. Brain 1996; 119:1497-1505.
17. Velazquez Pérez L, Sanchez Cruz G, Canales Ochoa N, et al. Electrophysiological features in patients and presymptomatic relatives with spinocerebellar ataxia type 2. Neurol Sci 2007; 263 (1-2):158 - 164.
18. Geiner S, Hom AK, Wadia NH, et al. The neuroanatomical basis of slow saccades in spinocerebellar ataxia type 2 (Wadia-subtype). Prog Brain Res 2008; 171:575-581.
19. Pogacar S, Ambler M, Conklin W, et al. Dominant spinopontine atrophy: report of two additional members of family W. Arch Neurol 1978; 35:156-162.
20. Liu J, Tang T, Tu H, et al. Deranged calcium signaling and neurodegeneration in spinocerebellar ataxia type 2. J Neuroscience 2009; 29:9148-9162.
21. Newman-Toker DE, Kattah JC, Alvernia JE, Wang DZ. Normal head impulse test differentiates acute cerebellar strokes from vestibular neuritis. Neurology 2008; 70 (24 Pt 2):2378-2385.
22. Jardim L, Pereira M, Silveira I, et al. Neurologic findings is Machado-Joseph disease. Arch Neurol 2001; 58:899-904.
23. Giunti P, Sweeney M, Harding A. Detection of the Machado-Joseph disease/spinocerebellar ataxia three trinucleotide repeat expansion in families with autosomal dominant motor disorders, including the Drew family of Walworth. Brain 1995; 118:1077-1085.
24. Chai Y, Berke S, Cohen R, Paulson H. Poly-ubiquitin binding by the poly-glutamine disease protein ataxin-3 links its normal function to protein surveillance pathways. J Biol Chem 2004; 279:3605-3611.
25. Gomez CM, Thompson RM, Gammack JT, et al. Spinocerebellar ataxia type 6: gaze-evoked and vertical nystagmus, Purkinje cell degeneration, and variable age of onset. Ann Neurol 1997; 42:933-950.
26. Kim JM, Lee JY, Kim HJ, et al. The wide clinical spectrum and nigrostriatal dopaminergic damage in spinocerebellar ataxia type 6. J Neurol Neurosurg Psychiatry 2010; 81:529-532.
27. Christova P, Anderson J, Gomez CM. Impaired eye movements in presymptomatic spinocerebellar ataxia type 6. Arch Neurol 2008; 65:530-536.
28. Colen C, Ketko A, George E, Van Stavern G. Periodic alternating nystagmus and periodic alternating skew deviation in spinocerebellar ataxia type 6. J Neuro-Ophthalmol 2008; 28:287-288.
29. Michalik A, Martin J, Van Broeckhoven C. Spinocerebellar ataxia type 7 associated with pigmentary retinal dystrophy. Eur J Hum Genet 2004; 12:2-15.
30. Inaba H, Yabe I, Yashima M, et al. Unusual retinal phenotypes in an SCA7 family. Inter med 2009; 48:1461-1464.
31. Jonasson J, Juvonen V, Sistonen P, et al. Evidence for a common spinocerebellar ataxia type 7 (SCA7) founder mutation in Scandinavia. Europ J Hum Genet 2000; 8:918-922.
32. Miller R, Tewari A, Miller J, et al. Neuro-ophthalmologic features of spinocer-ebellar ataxia type 7. J Neuro-ophthalmol 2009; 29:180-186.
33. Thurtell M, Fraser A, Bala E, et al. Two patients with spinocerebellar ataxia type 7 presenting with profound binocular visual loss yet minimal ophthalmoscopic findings. J Neuro-ophthalmology 2009; 29:187-191.
34. Manrique R, Noval S, Aguilar-Amat M, et al. Ophthalmic features of spinocer-ebellar ataxia type 7. J Neuro-ophthalmol 2009; 29:174-179.
35. Hugosson T, Gränse L, Ponjavic V, Andréasson S. Macular dysfunction and morphology in spinocerebellar ataxia type 7 (SCA 7). J Ophthalmic Genet 2009; 30:1-6.
36. Ahn JK, Seo JM, Chung H, Yu HG. Anatomical and functional characteristics in atrophic maculopathy associated with spinocerebellar ataxia type 7. Am J Ophthalmol 2005; 139:923-925.
37. Abou-Sleymane G, Chalmel F, Helmlinger D, et al. Polyglutamine expansion causes neurodegeneration by altering the neuronal differentiation program. Hum Molec Genet 2006; 15:691-703.